If You Invested in Neolara (NELR)
Looking for the current price? See the NELR quote & overviewWhat $1,000 or $10,000 in NELR Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Apr 22, 2025 |
|---|---|---|---|---|
| $1,000 | $5 -100% | — | — | $40 -96% |
| $10,000 | $48 -100% | — | — | $400 -96% |
Based on real historical closing prices, dividend- and split-adjusted, through 2026-07-23. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for NELR$1,000 Investment Over Time
NELR vs S&P 500Year-by-Year Returns
NELR annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2025 | $0.25 | $0.25 | +0.0% | +0.0% |
| 2026 | $2.10 | $0.01 | -99.5% | -96.0% |
About Neolara
OTC Link
Neolara Corp (symbol: NELR) is a corporation incorporated in the U.S. state of Wyoming, as disclosed in its reports filed under the Securities Exchange Act of 1934. According to an 8-K filed with the U.S. Securities and Exchange Commission, the company has a Commission File Number of 000-56687 and an Internal Revenue Service employer identification number of 98-1674969. While recent filings describe important corporate governance changes, they do not provide a detailed description of Neolara Corp’s operating business or industry classification.
The same 8-K filing lists a mailing location in Coto Brus, Puntarenas, Costa Rica, indicating that Neolara Corp maintains a connection to that region for corporate correspondence. However, the filing focuses on ownership and management changes rather than operational activities, and it does not specify the company’s sector, products, or services. As a result, publicly available regulatory information emphasizes Neolara Corp’s corporate structure and control rather than its day-to-day commercial operations.
Corporate control and governance
According to the 8-K dated September 19, 2025, a stock purchase agreement resulted in a change in control of Neolara Corp. The previous chief executive officer, director, and majority shareholder entered into an agreement to sell 2,000,000 shares of common stock, representing approximately 63% of the issued and outstanding common shares as of that date, to a new controlling shareholder, Cao Wei. This share transfer gives the buyer the ability to unilaterally influence the election of the board of directors and other matters requiring shareholder approval.
The same filing states that, effective on the date of the transaction, the prior executive officers and directors resigned from their positions, including roles such as Chief Executive Officer and President, and as members of the board. On that date, Cao Wei was appointed as Chief Executive Officer, Chief Financial Officer, Secretary, and sole Director of Neolara Corp. These disclosures highlight that the company’s governance is concentrated in a single individual following the reported change in control.
Board composition and professional backgrounds
The 8-K filing also provides background information about individuals associated with the board and management. It describes Cao Wei’s prior experience in architectural design and construction-related roles at several companies, as well as his Bachelor of Civil Engineering degree from Hubei University of Technology. This indicates that the controlling officer and director has a professional history in civil engineering and construction design.
In addition, the filing describes Li Yan as a director with experience in biomedical engineering roles, including positions focused on clinical validation of medical devices, product development, and technical support. Li Yan holds a Bachelor’s degree in Biomedical Engineering from Hubei University of Science and Technology. Another director, Lloveras Amador Ricardo, is described as having experience in software development and project management, including work on web applications, automated testing frameworks, and large-scale IT projects. He holds a Bachelor’s degree in Computer Engineering from the University of Barcelona.
These biographies show that Neolara Corp’s leadership and board-level participants have backgrounds spanning civil engineering, biomedical engineering, and software development. However, the 8-K does not state that Neolara Corp itself operates in these fields; it only documents the prior careers and education of the individuals involved.
Regulatory reporting and public company status
Neolara Corp files reports with the SEC under the Securities Exchange Act of 1934, as evidenced by the 8-K reports describing changes in control and management. The presence of a Commission File Number and the use of standard SEC item headings (such as Item 5.01 and Item 5.02) indicate that Neolara Corp is subject to ongoing reporting obligations. The filings focus on material events related to ownership and governance, which are key areas of interest for investors evaluating corporate control and board oversight.
Because the available filings do not describe the company’s revenue sources, business segments, or specific industry, investors researching Neolara Corp may rely heavily on these governance disclosures to understand who directs the company and how control is exercised. The concentration of ownership and management in a small group of individuals is a notable feature of the company’s current structure, as described in the 8-K.
Information limitations
Based on the information provided in recent SEC filings, Neolara Corp’s detailed business activities, sector classification, and product or service offerings are not specified. The filings instead emphasize corporate control, board composition, and the professional backgrounds of key individuals. As a result, any assessment of Neolara Corp using public regulatory documents will focus primarily on its status as a Wyoming corporation with a documented change in control and a board and management team whose experience spans engineering and software disciplines.
Prospective investors and researchers can use this information to understand the company’s legal jurisdiction of incorporation, the extent of ownership concentration, and the qualifications of its leadership, while recognizing that additional sources would be needed to obtain a full picture of Neolara Corp’s operational business model.
Frequently Asked Questions
Neolara investment returns
How much would $1,000 invested in Neolara be worth today?
If you invested $1,000 in Neolara (NELR) 1 years ago on 2026-06-29, your investment would be worth $5 as of 2026-07-23, representing a -99.5% total return, growing at a compounded rate of -100.0% per year (CAGR).
Has Neolara outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare NELR performance over available time periods.
What is Neolara's average annual return?
The compound annual growth rate (CAGR) of NELR over the past 1 years is -100.0%, growing at a compounded rate each year. Individual years vary significantly — NELR's best recent year was 2025 (+0.0%) and worst was 2026 (-99.5%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.